Page last updated: 2024-08-24

remifentanil and Anomalous Ventricular Excitation Syndrome

remifentanil has been researched along with Anomalous Ventricular Excitation Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujii, K; Hatano, Y; Iranami, H; Nakamura, Y	1

Trials

1 trial(s) available for remifentanil and Anomalous Ventricular Excitation Syndrome

Article	Year
High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia. Anesthesia and analgesia, 2011, Volume: 112, Issue:5 Topics: Action Potentials; Age Factors; Analgesics, Opioid; Anesthetics, Intravenous; Bundle of His; Catheter Ablation; Child; Female; Heart Atria; Humans; Infusions, Intravenous; Japan; Male; Periodicity; Piperidines; Propofol; Prospective Studies; Refractory Period, Electrophysiological; Remifentanil; Sinoatrial Node; Time Factors; Wolff-Parkinson-White Syndrome	2011

Article

Year

High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia.

Anesthesia and analgesia, 2011, Volume: 112, Issue:5

Topics: Action Potentials; Age Factors; Analgesics, Opioid; Anesthetics, Intravenous; Bundle of His; Catheter Ablation; Child; Female; Heart Atria; Humans; Infusions, Intravenous; Japan; Male; Periodicity; Piperidines; Propofol; Prospective Studies; Refractory Period, Electrophysiological; Remifentanil; Sinoatrial Node; Time Factors; Wolff-Parkinson-White Syndrome

2011